performed in a pRB deficient background, which gives rise to highly proliferative and undifferentiated tumors resembling primitive neuroectodermal tumors (PNETs). This could reveal cooperating genes that interact with rb1 to affect brain cancer. To this end, neural progenitors were targeted using the Tg(krt5:SB11) transgenic line. The ability of this transgenic to mobilize transposons was demonstrated in whole larvae and adult brains. Also, an inducible transposase source in the Tg(ubi:floxed-SB11) transgenic line was able to increase transposon mobilization in response to Cre injection, despite a low level of background expression. Other tissue-specific promoters were explored, including gfap and nestin, which may result in increased tumorigenesis.
Several mutagenesis screens are currently being monitored in both wild type and tumor susceptible backgrounds. Common integration sites in the zebrafish genome are also being mapped to aid in the analysis of data from these screens by removing background that does not contribute to tumorigenesis. A small scale mutagenesis screen in a wild type background has resulted in a single fish out of ten that developed a brain tumor after 8 months of age. Importantly, analysis showed that transposon mobilization was specific to tumor tissue, demonstrating that the Tg(krt5:SB11) transgenic line can (McClintock, 1950 (McClintock, & 1953 .Transposons are defined as segments of DNA that are capable of changing their location in the genome, leading to the popular name jumping genes. It is now known that transposons are present in almost every organism from prokaryotes to humans, and in many cases, make up a significant portion of the host genomes. Their discovery has not only led to a better understanding of our evolution and genetic past, but also has provided important genetic tools for research.
Types of Transposons
Transposable elements can be divided into two main groups corresponding to their mechanism of action (Pray, 2008) . Class I transposons are known as retrotransposons, named for the requirement of reverse transcriptase for mobilization.
Transposition is achieved by transcribing the transposon into an RNA intermediate.
Reverse transcriptase, encoded by the transposon, then produces a DNA copy of the transposon which can be integrated back into the host genome at the target site. The result is the duplication of the transposon from one site to the other, while leaving the original transposon behind. As a result, this is referred to a copy and paste mechanism.
The other group of transposon fall into class II, or DNA transposons. These do not require a RNA intermediate, but instead rely on a transposase that recognizes and binds to the transposon, excises it from the donor DNA, and then inserts it at the new target site. In contrast to the retrotransposons, DNA transposons exhibit a cut and paste mechanism. Due to the sequence specificity that each transposase recognizes, different transposons require a certain transposase to be mobilized.
In addition to these broad classifications, transposon can be further divided based on their ability to catalyze their own transposition. A transposon that encodes for the transposase or reverse transcriptase required for its own function is said to be autonomous. A non-autonomous transposon lacks this ability, and therefore requires other transposable elements for its mobilization.
Transposons in Research
The development of transposons has led to many research applications. In particular, the Tol2 and Sleeping Beauty transposon systems have had significant influence in research and are two transposons that will be used in this research. The Tol2 transposase system is a well characterized method for introducing transgenes into organisms (Kawakami, 2007 & Ni et al, 2016 . It is a class II, DNA transposon that requires the Tol2 transposase to catalyze transposon integration in the host genome.
Transgenes are constructed in a Tol2 transposon flanked by inverted repeats. For zebrafish, this DNA construct and transposase mRNA are injected into zebrafish at onecell stage. Although this results in mosaic integration of the transgene in injected fish, transgenic lines can be recovered from their offspring.
Sleeping Beauty Transposon
A good example of a transposable element being used for research purposes is the Sleeping Beauty transposon system. As the name implies, Sleeping Beauty (SB) was an inactive transposon found in the genome of a salmonid species that was engineered to restore its original function (Ivics et al., 1997) . A putative functional transposon sequence was generated based on phylogenetic analysis to obtain a consensus sequence with conserved domains. The revived SB transposon was then synthesized by eliminating the deleterious mutations to match this consensus sequence. This involved restoring the open reading frame of the transposase and repairing mutations to the DNA binding and catalytic domains. The restored transposase was named SB10 and was successfully used to drive transposition in human cells (Ivics et al., 1997) .
The SB transposon falls into the Tc1/mariner superfamily. This family includes DNA transposons that are present in a wide variety of organisms. This makes SB advantageous for use in vertebrate research as it has a wider host range (Plasterk et al., 1999) . Structurally, the transposon contains two terminal inverted repeats flanking the SB transposase gene (Ivics et al, 2015) . For research purposes, however, the transposase gene can be replaced with a gene of interest or other genetic cargo, and the transposase supplied through another method. This allows the SB transposon system to be used for a wide range of research applications (Izsvák et al., 2004) .
As a class II transposon, SB is mobilized by the cut and paste method (Walisko et al., 2008) . Transposition begins when SB transposase binds to the inverted repeats on the transposon, with two units of the transposase at each end. The synaptic complex forms as the transposase subunits bind, bringing the two ends together, resulting in DNA cleavage.
Finally, the transposon is excised from the donor site and is introduced at a new target site. The resulting double stranded break in the donor DNA is repaired by nonhomologous end joining. One of the advantages of the SB system is that the target site requirements for transposition have few restrictions, only requiring a TA dinucleotide.
These qualities of have made the SB transposon an important tool in research.
CHAPTER II TRANSPOSON SOMATIC MUTAGENESIS

Background
The use of transposon insertional mutagenesis is valuable for forward genetic screens. This kind of approach is important as it reveals new targets for cancer research to pursue (Mann et al., 2014) . Several studies have been done in mice using the SB11 transposon system to identify cancer genes through the disruption of random genes throughout the genome (Collier et al, 2005 , Moriarity et al., 2015 , and the system has been used in zebrafish by our lab (McGrail et al., 2011) . Zebrafish offer several advantages as a vertebrate model organism for forward genetic screens.
They have a short generation time and high fecundity, resulting in great numbers of individuals in a relatively short amount of time. Their genome has been sequenced and a number of genetic tools have been developed for their use, including transposons for generating transgenics and genome editing techniques. The ability to study specific genes and their role in cancer has improved dramatically since the utilization of TALENs and CRISPRs. However, forward genetic approaches are still required to better understand tumorigenesis by identifying novel genes that contribute to the cancer phenotype.
Transposon mutagenesis screens are often carried out in a tumor-susceptible background. This allows for the discovery of cooperating genes that interact to contribute to cancer. In the pRB model, in which rb1 is targeted using TALENs, adult mosaic mutants develop tumors that share characteristics of a type of cancer called PNETs (Solin et al., 2015) . Primitive neural ectodermal tumors (PNETs) are a form of highly malignant brain cancer that usually affects children and has a low survivability (Smoll, 2012) . A somatic insertional mutagenesis screen in the pRB model should identify cooperating genes leading to the PNET phenotype.
The somatic insertional mutagenesis screen using the SB11 system involves two In this research, a tissue-specific and inducible transposase source will be used to drive somatic transposon mutagenesis to identify novel genes that contribute to tumorigenesis. The ability to direct mutagenesis to specific cell types in an inducible manner is a very valuable technique in studying tumorigenesis. It would allow mutagenesis in the cell types of interest and their future lineages, as well as after critical stages of development. Neural progenitors are of particular interest for our PNET model. Several reports have shown that neural progenitors can be targeted through the use of the keratin5 (krt5) promoter. Tumorigenesis was promoted when using the krt5 promoter as a driver to activate the Sonic hedgehog signaling pathway (Ju et al., 2014) . It was also used to drive overexpression of human KRAS in zebrafish, resulting in malignant brain tumors (Ju et al., 2015) . Therefore, this promoter will be used to drive SB11 transposase expression for the mutagenesis screens.
In addition to targeting the transposon mutagenesis screen in specific tissues, it can also be controlled using an inducible transposase source. This will be accomplished using the Cre-Lox system and a tamoxifen-inducible Cre. Expression of SB11 transposase will be prevented until the tamoxifen is introduced. Driving the inducible Cre from a tissue specific promoter would allow for both the spatial and temporal control of the mutagenesis screen. Taking this forward genetics approach, the transposon mutagenesis screen should reveal novel genetic drivers of tumorigenesis and provide candidate genes for future study. This will help gain a better understanding of the mechanisms of tumorigenesis and could provide insights into possible treatments.
Methods
Cloning constructs for the expression of a transgene
All PCR reactions described were performed with KOD master mix, following the manufacturer's protocol. Primer sequences are provided in Table 1 . The krt5 promoter was cloned from zebrafish genomic DNA. Two pairs of primers were designed for a nested PCR. In the first round of PCR, the target sequence was amplified with the surrounding 30-40 bps. The second round of PCR used the resulting product as template to amplify up the target sequence to obtain the krt5 promoter flanked by restriction sites.
The restriction sites NotI and NheI were used to insert the amplified promoter into a vector to create pTol2<krt5:SB11, cmcl2:GFP>. The construct pTol2<gfap:SB11, cmlc2:GFP> was similarly made by amplifying the gfap promoter from a plasmid obtained from Addgene (#39761). The pTol2<krt5:SB11, cmcl2:GFP> plasmid was modified to pTol2<krt5:GFP> by digesting with NheI and AgeI to remove the SB11 coding region to the cmcl2 promoter, followed by a blunt end ligation.
The ubiquitin promoter used in the Tg(ubi:floxed-SB11) construct was obtained from Addgene (#27320). The promoter region was excised using the restriction sites NheI and BamHI, and inserted into a vector to create pTol2<ubi:floxed-SB11, cmlc2:GFP>. The termination signal consisting of two SV40 sequences surrounded by LoxP sites was amplified from a plasmid template. The BamHI restriction sites were used to insert this transcription terminator sequence between the ubiquitin promoter and SB11 coding region to yield pTol2<ubi:floxed-SB11, cmlc2:GFP>. The pTol2<ubi:GFP> plasmid was obtained by digesting pTol2<ubi:floxed-SB11, cmlc2:GFP> with BamHI and AgeI to remove the floxed-SB11 and cmlc2 promoter, followed by a blunt end ligation. The nestin promoter was amplified from genomic DNA and cloned directly into the pCR-BluntII-Topo vector. This allowed the promoter to be cloned into the p5'E:MCS vector using the restriction sites KpnI and SacII to yield p5'E:nestin. 
Primer Name
Sequence (5' to 3') krt5-nested-forward GCTCATGCTTCCACTACTGG krt5-nested-reverse AGAACTGGGAAACTGAGACTG krt5-promoter-forward ATTAGCGGCCGCGAAAGCGACTCCACCC krt5-promoter-reverse ATTAGCTAGCGAGGGGGTGAGGATCAGA loxP-SV40-forward ATTAGGATCCTCCGGAATTCATAACTTCG loxP-SV40-reverse ATTAGGATCCTGCAGGATATCGATATAACTTC gfap-promoter-forward ATTAGCTAGCGAGGTAAGGACTGAGGTG gfap-promoter-reverse ATTAGCATGCGGTGGAGGAGAATGAG nestin-promoter-forward AGTCGGTACCAGGAAGTTTCCAGTGTTGTG nestin-promoter-reverse AGCTCCGCGGTCACTAGAGGCTGTGAAGAA
Generating and characterizing transgenic zebrafish lines
Transgenics were created by co-injecting the vector containing the transgene in the Tol2 backbone with Tol2 transposase. For each transgenic line, 50 pg of the construct and 125 pg of the Tol2 mRNA was injected. Injected embryos were screened for a reporter gene and founders were identified.
SB11 expression in the Tg(krt5:SB11) was analyzed using whose mount in situ hybridization on 2 day old larvae. The probe was the entire antisense SB11 coding region.
The control included was the leptin b probe, which has been used previously. The ability of these transgenic lines to mobilize the transposon was determined using a transposon excision assay, in which PCR was used to amplify specific sequences along the transposon. Primers were previously designed to amplify across the excision site and the left arm of the transposon. These sequences are provided in Table 2 . The Tg(ubi:floxed-SB11) system was tested by injecting of 50 pg Cre mRNA into progeny from a cross with T2/OncZ. Injected and uninjected larvae were raised to 5 days of age, separated according to genotype, and used to extract genomic DNA. The transposon excision assay was used to determine if SB11 was being expressed. transposon line. Progeny were separated based on genotype and raised to adulthood. At 2 months of age, the fish were sacrificed and the entire trunk of the body used for genomic DNA extraction. Linker mediated PCR was used to amplify insertion sites (McGrail et al., 2011) . The libraries were constructed using the primers listed in Table 3 . A total of 48 samples were prepared for each arm of the transposon. Samples were barcoded with one of 24 barcoded primers, listed in Table 4 . The first set of samples containing 24 libraries from the left transposon arm were sent for sequencing on the MiSeq with 150-cycles.
In order to ensure that the common integration site libraries contained sequences of the transposon flanking genomic DNA, random clones were isolated and sequenced.
Each sample was run on a gel and excised, purified, and used for TA cloning. This allowed random fragments from each sample to be cloned into the pCR4-Topo vector.
Clones were selected and individual colonies were grown up. The plasmid DNA was sent for standard Sanger sequencing. 
Results
Isolation of transgenic lines for tissue specific and inducible transposase sources
In this research, transposon somatic mutagenesis will be used to identify genetic drivers that contribute to the development of the PNET phenotype. To accomplish this, tissue specific and inducible transposase sources were explored. The design of the constructs used to create these transgenic zebrafish lines is illustrated in Figure 1 . The number of independent lines of each transgenic is summarized in Table 5 . The targeting of neural progenitors is of particular interest, as these cells are thought to be the origin of over proliferation in our model. Studies have shown that the krt5 promoter could be used to drive tumorigenesis in the brain by targeting neural progenitors (Ju et al., 2014) . This promoter was therefore chosen to drive transposase expression for the mutagenesis screens. In total, three independent transgenic lines of Tg(krt5:SB11) were isolated. Table 5 . Number of independent lines of each transgenic that has been isolated.
The ability of the Tg(krt5:SB11) transgenic line to drive transposon mobilization was tested with a small scale mutagenesis screen by crossing with the T2/OncZ line.
Transposon mobilization was measured using an excision assay, which is shown in In addition to tissue-specificity, and inducible transposase source would be advantageous for initiating transposon mutagenesis after critical stages of development.
A common method for achieving inducible control of a transgene is the Cre-Lox system, which was to be used in this research. One part of this system has been developed so far. Other tissue specific promoters expressed in the brain that were explored include gfap and nestin promoters. These promoters have been used as reporters for radial glia and stem cells in the brain (Lam et al., 2009) . Progress has been made in cloning these promoters into several constructs, but transgenic lines have not yet been produced. The gfap promoter has been cloned into the pTol2<gfap:SB11, cmlc2:GFP> vector to drive SB11 expression. However, there are alternative translation start sites upstream of the SB11 coding region that may prevent or hinder SB11 from being successfully translated.
Before this construct is used to create a transgenic line, these alternative start sites should be removed. The nestin promoter was cloned successfully from genomic DNA and inserted into a multiple cloning site vector.
The construction of these plasmids opened up the ability to create another transgenic line that would be beneficial in the lab. This construct was modified to drive the ubiquitous expression of GFP, which lead to the establishment of the Tg(ubi:GFP)
line. This transgenic has been used for several experiments involving transplantation.
The transgenics expressing transposase sources were designed and constructed in this research to catalyze the mobilization of a transposon in two other lines, shown in 
Mapping common integration sites of the T2OncZgb1 transposon following mobilization
Common integration sites are being mapped following the mobilization of the T2OncZgb1 transposon by the Tg(β-actin:SB11) transgenic line. This will identify integration hotspots in the genome, which will allow these sites to be removed as background when analyzing the data from somatic mutagenesis screens. At 2 months of age, the double transgenics were sacrificed and genomic DNA was extracted for library preparation. In total, 48 individual fish produced libraries for the right and left transposon arms. Each library was prepared with a barcoded primer that would allow multiplexing during sequencing.
In order to verify that the constructed libraries contained fragments of genomic DNA surrounding the transposon insertion site, several random amplified products were cloned and sequenced using standard sequencing. The results revealed that most of the samples contained transposon concatemer sequence, instead of mapping to the genome.
However, these segments were flanked by the sequencing and linker primers used to construct the libraries. In addition, the barcode sequence corresponding to the library sample was recovered. This suggested that the library construction was successful and ready for next generation sequencing. Figure 8 . In particular, there appears to be a common integration site on chromosome 3 at the β-actin promoter. This was observed previously as well (McGrail et al., 2011) . The process of mapping the reads to the zebrafish genome will identify common integration sites, and is currently underway. 
Genome wide mutagenesis in to screen for tumor suppressors and oncogenes
Transposon mutagenesis screens were targeted to neural progenitors using the described transgenic lines. Four separate screens are currently being monitored in the lab, including two screens using the T2/OncZ transposon line and two with the T2/OncZgb1
transposon line. The first screen using the Tg(krt5:SB11) transgenic was with the T2/OncZ transposon line. A second screen using this cross was setup to examine changes in tumorigenesis in the pRB deficient background by injecting CRISPRs into single-cell stage embryos. However, analysis showed that there was no mutagenesis at the rb1 locus.
As a result, these fish were raised as a wild type background. These screens are summarized in Table 6 . Of this second screen, one individual out of 10 showed tumor formation. Performing the excision assay in Figure 9 , it was shown that transposon mobilization was detected in the tumor tissue, but not in the control muscle tissue. This indicates that the Tg(krt5:SB11) transgenic can induce tumorigenesis by mobilization of the transposon in specific tissues. Due to the limited numbers of fish involved in this screen, the significance of these results can not be established. A similar large scale screen is also being monitored using the T2/OncZgb1 transposon line. Transposon mobilization was again confirmed in double transgenics using an excision assay of larvae. In addition, an excision assay performed on dissected brains of adult individuals showed transposon mobilization in the presence of the transposase in the Tg(krt5:SB11) transgenic. Lastly, the other screen in progress was done in the pRB deficient background. This was achieved by targeting rb1 with TALENs to create mosaic mutants that are known to give raise to tumorigenesis. These screens are summarized in Table 7 . The inducible Tg(ubi:floxed-SB11) transposase source has also been generated and tested. It was shown that the transgenic line could increase transposon mobilization with Cre recombinase. However, there was a small amount of SB11 expression that is ubiquitous, suggesting the 2xSV40 transcription terminator that was used is leaky.
Refinements to this system could include replacing the 2xSV40 with a stronger terminator. This modification would be required to make this a viable method for an inducible transposon mutagenesis system.
The construction of the libraries for the common integration site analysis is completed, and the data is currently being analyzed. The results should show hotspots for transposon integration, as well as local hopping around the location of the transposon concatemer. This data will be beneficial when analyzing the mapping results from the mutagenesis screens.
In the course of this research, several molecular tools and transgenic zebrafish lines have been generated for transposon mutagenesis. It is known that cancer results from a complex interaction of several factors. These transposon mutagenesis screens will therefore be important to identify cooperative genes that affect tumorigenesis in the brain.
Discovering the genetic mechanisms that drive proliferation of neural progenitors will provide insights into possible treatment of brain cancers, including PNETs. A more complete understanding of the genetic landscape of PNETs will lead to new treatments that will have a positive impact on human lives.
APPENDIX QUANTIFYING DIFFERENTIAL GENE EXPRESSION IN AN OPTIC PATHWAY TUMOR LINE
In a previous study, the lab characterized the transgenic zebrafish line Tg(flk1:RFP)is18, which developed tumors in the optic pathway (Solin et al., 2014) .
These tumors exhibited properties of retinoblastoma and fibrous glioma. It was determined that the tumors were caused by the disruption of a long, intergenic noncoding RNA gene lincRNAis18. A part of the characterization of this mutant line was transcriptome analysis of pre-tumor and tumor retina using RNAseq. The purpose of my experiments in this study was to validate the RNAseq data for several key genes using quantitative PCR in order to measure differences in gene expression. These genes included ajap1, ascl1a, atf3, bysl, hbegfa, and insm1a.
Primers were designed for each gene of interest to amplify 100-110 bp amplicon. Table 8 provides the primer sequences. A standard curve for each primer pair was constructed to test for primer efficiency and determine any off target amplification. This was achieved through a 1 to 10000 dilution of control cDNA. A two-step qRT-PCR was performed using SYBR green master mix. Each reaction was performed in triplicate.
Template consisted of 50 ng of control, pre-tumor, and tumor cDNA samples. cDNA was reverse transcribed from tissue samples using oligo-dT primers and the Invitrogen SuperScript III kit. qRT-PCR was performed on the LightCycler instrument. Fold change was calculated using β-actin as an endogenous control.
The differential gene expression measured using qRT-PCR was similar to the RNAseq results, as shown in Figure 10 . In most cases, a greater increase in gene expression was observed. In particular, ascl1a and hbegfa showed a much higher fold change than was detected using RNAseq. The results show that the tumor suppressor 
